Microbial safety of cell based medicinal products - What can we learn from cellular blood components?

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 7, 2008, Pages 963-965

  Montag, Thomas ^a   Nicol, Sven Boris ^a   Schurig, Utta ^a   Heiden, Margarete ^a   Huber, Helga ^a   Sanzenbacher, Ralf ^a   Flory, Egbert ^a   Schwanig, Michael ^a   Schneider, Christian K ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL THERAPY AGENT;

BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BLOOD CELL; BLOOD COMPONENT; CELL THERAPY; DISINFECTION; DRUG MANUFACTURE; DRUG SAFETY; DRUG STERILITY; PRIORITY JOURNAL; SHORT SURVEY;

BACTERIA; BACTERIAL INFECTIONS; BLOOD BANKS; BLOOD CELLS; CELLS; DRUG CONTAMINATION; HUMANS; SAFETY;

EID: 47349108855     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.175     Document Type: Short Survey

References (3)

1. European Pharmacopoeia 5.0: 2.6.1. Sterility.
2. Bundesärztekammer im Einvernehmen mit dem Paul-Ehrlich-Institut Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie), Gesamtnovelle 2005.
3. European Pharmacopoeia 5.6: 2.6.27. Microbiological control of cellular products.